期刊文献+

醋酸丙氨瑞林对人子宫内膜癌裸鼠皮下移植瘤生长的影响 被引量:3

Effection of alarelin on human endometrial carcinoma in nude mice of subcutaneous xenograft
暂未订购
导出
摘要 目的探讨不同剂量醋酸丙氨瑞林(alarelin acetate)对人子宫内膜癌裸鼠皮下移植瘤生长的影响及作用机制。方法建立裸鼠移植瘤模型,将荷瘤裸鼠随机分为4组:实验对照组,醋酸丙氨瑞林低、中、高剂量组(0、20、40、80μg/kg)。治疗期间定期测量肿瘤大小,观察裸鼠全身状况。治疗4周后,将移植瘤完整取出,称取瘤质量,计算抑瘤率。利用免疫组织化学法检测移植瘤组织中livin蛋白的表达。结果醋酸丙氨瑞林低、中、高剂量组的抑瘤率分别为17.8%、26.5%和43.6%,与对照组比较,醋酸丙氨瑞林各治疗组肿瘤生长缓慢,差异有统计学意义(P<0.05)。免疫组织化学结果:与对照组相比,醋酸丙氨瑞林各治疗组livin蛋白的表达水平明显降低,且各治疗组间差异有统计学意义(P<0.05)。结论不同剂量的醋酸丙氨瑞林均能抑制人子宫内膜癌裸鼠移植瘤的生长,且呈剂量依赖关系,其作用机制可能与下调livin蛋白表达有关。 Objective To investigate the effects of different doses of alarelin on human endometrial carcinoma in nude mice of subcutaneous xenograft and to explore its mechanisms.Methods Hunman endometrial carcinoma models were established by subcutaneous transp1antation in nude mice,and then they were randomly divided into 4 groups:control group,alarelin groups(0、20、40、80 μg/kg,respectively).During the period of treatment,the size and volume of tumor were measured and the systemic conditions of the mice were observed.At the end of the trial,the tumor was removed and the volume and weight of tumor were measured.The inhibitive rate was caculated and the expression of PCNA and VEGF was detected with immunohistochemical technology.Results Alarelin 20、40、80 μg/kg inhibited tumor growth by 17.8%、26.5% and 43.6%,respectively.The tumor grew slowly in each alarelin group compared with the control group.The difference was significant(P0.05,respectively).The immunohistochemical results showed that the expression of livin decreased obviously in treated groups compared with control group(P0.05,respectively).Conclusion Different doses of cisplatin significantly suppress tumor growth of xenografted human endometrial carcinoma in nude mice in a dose-dependent manner,which may be related to the down-regulation of livin protein.
出处 《中国药物与临床》 CAS 2011年第2期151-153,共3页 Chinese Remedies & Clinics
关键词 子宫内膜肿瘤 醋酸丙氨瑞林 Endometrial neoplasms Alarelin acetate
  • 相关文献

参考文献7

  • 1高春英,于伟,郭盛菊.子宫内膜癌治疗的新进展[J].中国妇幼保健,2005,20(9):1155-1156. 被引量:14
  • 2Lhomme C,Vennin P,Callet N,et al.A multicenter phase study with triptorelin (sustained-relesse LHRH agonist) in advanced or recurrent endometrial carcinoma:a French anticancer federation study.Gynecol Oneol,1999,75(2):187-193.
  • 3Jeyarajah AR,Gallagher CJ,Blake PR,et al.Long-term followup of gunadotrophin-releasing hormone analog treatment for recurrent endometrial cancer.Gynecol Oncol,1996,63(1):47-52.
  • 4Noci I,Coronnello M,Borri P,et al.Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro.Cancer Lett,2000,150(1):71-78.
  • 5贾培媛,王玉霞.促性腺激素释放激素及其受体在肿瘤治疗中的应用[J].国际药学研究杂志,2009,36(3):179-183. 被引量:8
  • 6Yagihashi A,Asanuma K,Kobayashi D,et al.Detection of autoantibodies to livin and surviving in sera from lung cancer patients.Lung Cancer,2005,48 (2):217-221.
  • 7Kasof GM,Gomcs BC.Livin,a novel inhibitor of apoptosis protein family member.J Biol Chem,2001,276(5):3238-3246.

二级参考文献37

  • 1Neill JD.GnRH and GnRH receptor genes in the human genome[J].Endocrinology,2002,143(3):737-743.
  • 2Hiney JK,Sower SA,Yu WH,et al.Gonadotropin-releasing hormone neurons in the preoptic hypothalamic region of the rat contain lamprey gonadotropin-releasing hormone-Ⅲ,mammalian luteinizing hormone-releasing hormone,or both peptides[J].Proc Natl Acad Sci USA,2001,99(4):2386-2391.
  • 3Millar RP.GnRH Ⅱ and type Ⅱ GnRH receptors[J].Trends Endocrinol Metab,2003,14(1):35-43.
  • 4Naor Z.Signaling by G-protein-coupled receptor (GPCR):studi-es on the GnRH receptor[J].Neuroendocrinology,2009,30(1):10-29.
  • 5Cheng CK,Leung PCK.Molecular biology of gonadotropin-releasing hormone (GnRH)-Ⅰ,GnRH-Ⅱ,and their receptors in humans[J].Endocr Rev,2005,26(2):283-306.
  • 6Pawson AJ,Faccenda E,Maudsley S,et al.Mammalian type Ⅰ gonadotropin-releasing hormone receptors undergo slow,constitutive,agonist-independent internalization[J].Endocrinology,2008,149(3):1415-1422.
  • 7Silver MR,Nucci NV,Root AR,et al.Cloning and characterization of a functional type Ⅱ gonadotropin releasing hormone receptor with a lengthy carboxy-terminal tail from an ancestral vertebrate,the sea lamprey[J].Endocrinology,2005,146(8):3351-3361.
  • 8Silver MR,Kawauchi H,Nozaki M,et al.Cloning and analysis of the lamprey GnRH-Ⅲ cDNA from eight species of lamprey representing the three families of Petromyzoniformes[J].Gen Comp Endocrinol,2004,139(1):85-94.
  • 9Grundlker C,Gunthert AR,Millar RP,et al.Expression of go-nadotropin-releasing hormone Ⅱ (GnRH-Ⅱ) receptor in human endometrial and ovarian cancer cells and effects of GnRH-Ⅱ on tumor cell proliferation[J].J Clin Endocrinol Metab,2002,87(3):1427-1430.
  • 10Mangia A,Tommasi S,Reshkin SJ,et al.Gonadotropin releasing hormone receptor in primary breast cancer:comparison of immunohistochemical,radioligand and Western blot analyses[J].Oncol Rep,2002,9(5):1127-1132.

共引文献20

同被引文献25

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部